Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$4.98M
66.76K shares
What this filing means
ZANTE GREG plans to sell 66.76K shares of VIKING THERAPEUTICS, INC. valued at approximately $4.98M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/3/2024ACC: 0000103623-24-000054
Officer· Chief Financial Officer
Since Jan 2021
66.76K
Shares to sell
$4.98M
Approx. market value
32.51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
RSU
N/A
1/4/2024
7.68KRSU
N/A
1/3/2024
10.10KRSU
N/A
1/3/2024
2.11KESPP
N/A
11/20/2023
9.94KESPP
N/A
5/19/2023
1.17KRSU
N/A
4/3/2023
750.00RSU
N/A
4/3/2023
750.00Total acquired32.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2024 | RSU N/A | 7.68K | — |
1/3/2024 | RSU N/A | 10.10K | — |
1/3/2024 | RSU N/A | 2.11K | — |
11/20/2023 | ESPP N/A | 9.94K | — |
5/19/2023 | ESPP N/A | 1.17K | — |
4/3/2023 | RSU N/A | 750.00 | — |
4/3/2023 | RSU N/A | 750.00 | — |
| Total | 32.51K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
66.76K
Market value
$4.98M
5/3/2024
Total
Units
66.76K
Value
$4.98M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/3/2024 | 66.76K | $4.98M | NASDAQ | Planned |
| Total | 66.76K | $4.98M | ||